These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

417 related articles for article (PubMed ID: 21405971)

  • 1. Lung cancer biomarkers in exhaled breath.
    Amann A; Corradi M; Mazzone P; Mutti A
    Expert Rev Mol Diagn; 2011 Mar; 11(2):207-17. PubMed ID: 21405971
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Exhaled biomarkers in lung cancer.
    Horváth I; Lázár Z; Gyulai N; Kollai M; Losonczy G
    Eur Respir J; 2009 Jul; 34(1):261-75. PubMed ID: 19567608
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A study of the volatile organic compounds exhaled by lung cancer cells in vitro for breath diagnosis.
    Chen X; Xu F; Wang Y; Pan Y; Lu D; Wang P; Ying K; Chen E; Zhang W
    Cancer; 2007 Aug; 110(4):835-44. PubMed ID: 17599760
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The analysis of volatile organic compounds biomarkers for lung cancer in exhaled breath, tissues and cell lines.
    Wang Y; Hu Y; Wang D; Yu K; Wang L; Zou Y; Zhao C; Zhang X; Wang P; Ying K
    Cancer Biomark; 2012; 11(4):129-37. PubMed ID: 23144150
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Molecular diagnosis of lung cancer].
    Corradi M; Poli D; Goldoni M
    G Ital Med Lav Ergon; 2008; 30(3 Suppl):115-6. PubMed ID: 19288801
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quantitative breath analysis of volatile organic compounds of lung cancer patients.
    Song G; Qin T; Liu H; Xu GB; Pan YY; Xiong FX; Gu KS; Sun GP; Chen ZD
    Lung Cancer; 2010 Feb; 67(2):227-31. PubMed ID: 19409642
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ion mobility spectrometry for the detection of volatile organic compounds in exhaled breath of patients with lung cancer: results of a pilot study.
    Westhoff M; Litterst P; Freitag L; Urfer W; Bader S; Baumbach JI
    Thorax; 2009 Sep; 64(9):744-8. PubMed ID: 19158121
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Progress in the development of volatile exhaled breath signatures of lung cancer.
    Mazzone PJ; Wang XF; Lim S; Jett J; Choi H; Zhang Q; Beukemann M; Seeley M; Martino R; Rhodes P
    Ann Am Thorac Soc; 2015 May; 12(5):752-7. PubMed ID: 25965541
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Breath testing as a method for detecting lung cancer.
    Taivans I; Bukovskis M; Strazda G; Jurka N
    Expert Rev Anticancer Ther; 2014 Feb; 14(2):121-3. PubMed ID: 24467216
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Breath analysis in asbestos-related disorders: a review of the literature and potential future applications.
    Chapman EA; Thomas PS; Yates DH
    J Breath Res; 2010 Sep; 4(3):034001. PubMed ID: 21383477
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An electronic nose in the discrimination of patients with non-small cell lung cancer and COPD.
    Dragonieri S; Annema JT; Schot R; van der Schee MP; Spanevello A; Carratú P; Resta O; Rabe KF; Sterk PJ
    Lung Cancer; 2009 May; 64(2):166-70. PubMed ID: 18834643
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A review of novel biological tools used in screening for the early detection of lung cancer.
    Ghosal R; Kloer P; Lewis KE
    Postgrad Med J; 2009 Jul; 85(1005):358-63. PubMed ID: 19581246
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Breath carbonyl compounds as biomarkers of lung cancer.
    Li M; Yang D; Brock G; Knipp RJ; Bousamra M; Nantz MH; Fu XA
    Lung Cancer; 2015 Oct; 90(1):92-7. PubMed ID: 26233567
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diagnostic accuracy of canine scent detection in early- and late-stage lung and breast cancers.
    McCulloch M; Jezierski T; Broffman M; Hubbard A; Turner K; Janecki T
    Integr Cancer Ther; 2006 Mar; 5(1):30-9. PubMed ID: 16484712
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Influences of mixed expiratory sampling parameters on exhaled volatile organic compound concentrations.
    Thekedar B; Oeh U; Szymczak W; Hoeschen C; Paretzke HG
    J Breath Res; 2011 Mar; 5(1):016001. PubMed ID: 21383425
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Exhaled breath analysis: novel approach for early detection of lung cancer.
    Chan HP; Lewis C; Thomas PS
    Lung Cancer; 2009 Feb; 63(2):164-8. PubMed ID: 18599152
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Organic metabolites in exhaled human breath--a multivariate approach for identification of biomarkers in lung disorders.
    Gaspar EM; Lucena AF; Duro da Costa J; Chaves das Neves H
    J Chromatogr A; 2009 Apr; 1216(14):2749-56. PubMed ID: 19036381
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Review of recent developments in determining volatile organic compounds in exhaled breath as biomarkers for lung cancer diagnosis.
    Zhou J; Huang ZA; Kumar U; Chen DDY
    Anal Chim Acta; 2017 Dec; 996():1-9. PubMed ID: 29137702
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular diagnosis of lung cancer: an overview of recent developments.
    Mutti A
    Acta Biomed; 2008; 79 Suppl 1():11-23. PubMed ID: 18924306
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Quantitative analysis of exhaled carbonyl compounds distinguishes benign from malignant pulmonary disease.
    Bousamra M; Schumer E; Li M; Knipp RJ; Nantz MH; van Berkel V; Fu XA
    J Thorac Cardiovasc Surg; 2014 Sep; 148(3):1074-80; discussion 1080-1. PubMed ID: 25129599
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.